Organization Profile

You just read:

Biogen responds to coverage recommendation by the Canadian Drug Expert Committee (CDEC) for SPINRAZA, the only treatment approved for treatment of 5q Spinal Muscular Atrophy (SMA)

News provided by

Biogen Canada Inc.

Dec 22, 2017, 16:11 ET